Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R4ML
|
||||
Former ID |
DIB002049
|
||||
Drug Name |
P1A
|
||||
Synonyms |
IPSAT P1A; P1A, Ipsat Therapies
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Toxicity [ICD10:T36-T50, T51-T65] | Discontinued in Phase 2 | [547883] | ||
Company |
Ipsat Therapies Oy
|
||||
Structure |
Download2D MOL |
||||
Formula |
C27H44O6
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Beta-lactamase | Target Info | Modulator | [530289] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.